On Feb 1, 2022 Biofidelity closed a Series A round and raised $23,000,000 from Octopus Ventures, SBI Investment, featuring lead investors Octopus Ventures.
About the company: Biofidelity is located at United Kingdom, Europe.
“High sensitivity molecular assays for detection of genetic abnormalities with simple workflow and fast time-to-result, without the need for DNA sequencing.”
Company website: http://www.biofidelity.com